Pharmacies Hit By Restrictions On 340B Drug Discounts

By John Wilkerson / November 2, 2022 at 3:21 PM
Walgreens will lose about $250 million in profits in fiscal 2022 and 2023 due to drug companies restricting 340B discounts to hospitals and clinics, according to Drug Channels CEO Adam Fein. After a decade of booming business from 340B, pharmacies now are losing some of that revenue. Hospitals that get 340B drug discounts have received most of the attention from the restrictions that drug companies began placing on 340B discounts in 2020, but pharmacies are losing money, too. Fein said...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.